Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Ultragenyx Pharmaceutical Inc.

RARE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
RARE Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
RARE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RARE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in RARE holdings by institutional investors

Quarterly net insider trading by RARE's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $390,000 Jul 20, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $440,000 Apr 17, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $130,000 Jan 16, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $140,000 Oct 17, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $140,000 Jul 21, 2025 Issue: None
  • $330,000 Apr 21, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $110,000 Jan 20, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $80,000 Oct 21, 2024 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $30,000 Jul 22, 2024 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $40,000 Jan 11, 2024 Issue: Health Issues
  • $40,000 Oct 17, 2023 Issue: Health Issues
  • $60,000 Jul 16, 2023 Issue: Health Issues
  • $50,000 May 03, 2023 Issue: Health Issues
  • $50,000 Oct 17, 2022 Issue: Health Issues
  • $50,000 Jul 17, 2022 Issue: Health Issues
  • $50,000 Apr 17, 2022 Issue: Health Issues
  • $50,000 Jan 20, 2022 Issue: Pharmacy Health Issues
  • $50,000 Jan 18, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues Pharmacy
  • $50,000 Oct 19, 2021 Issue: Health Issues
  • $45,000 Jul 20, 2021 Issue: Health Issues
  • $20,000 Jul 19, 2021 Issue: Health Issues
  • $50,000 Jul 18, 2021 Issue: Health Issues
  • $50,000 Apr 20, 2021 Issue: Pharmacy Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues
  • $10,000 Apr 19, 2021 Issue: Health Issues
  • $50,000 Jan 21, 2021 Issue: None
  • $40,000 Jan 20, 2021 Issue: Budget/Appropriations Health Issues
  • $20,000 Oct 20, 2020 Issue: Pharmacy Health Issues
  • $50,000 Oct 20, 2020 Issue: Budget/Appropriations Health Issues
  • $50,000 Jul 20, 2020 Issue: Pharmacy
  • $40,000 Jul 19, 2020 Issue: Health Issues
  • $10,000 Apr 20, 2020 Issue: Pharmacy
  • $40,000 Apr 20, 2020 Issue: Health Issues
  • $40,000 Jan 20, 2020 Issue: Health Issues

Former government officials who have lobbied for RARE

46 former government officials from 32 congressional offices at 7 lobbying firms have lobbied for RARE, most recently Jul 20, 2026.

  • A. Donald McEachin
    Keenan Austin Reed House Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson Formerly with A. Donald McEachin · ALPINE GROUP PARTNERS, LLC. · Jul 20, 2026
  • Anna G. Eshoo
    Erin Mendelsohn House LD, Rep. Anna Eshoo; Congressional Liaison - FDA Formerly with Anna G. Eshoo · ALPINE GROUP PARTNERS, LLC. · Jul 20, 2026
  • Tim Scott
    Shayne Woods Senate Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep. Gus Bilirakis Formerly with Tim Scott · ALPINE GROUP PARTNERS, LLC. · Jul 20, 2026
  • Ashley Gunn House New Special Asst to the President, Senior Director, White House Office of Cabinet Affairs. Formerly Special Asst to the President, Senior Director, White House Office of Cabinet Af · MILLER STRATEGIES, LLC · Apr 20, 2026
  • Natalie Mcintyre Congress New Special Assistant to the President, Office of Legislative Affairs; Sen. Bill Hagerty Legislative Director; OMB Deputy Associate Director, Legislative Affairs; ONDCP Senior Policy Advisor and White House Liaison; Sen. McConnell Legislative Assistant Formerly Bill Hagerty Legislative Director · MILLER STRATEGIES, LLC · Apr 20, 2026
  • Mike Crapo
    Barrett Thornhill Senate New Legislative Assistant, Sen. Mike Crapo (2003-2006) Formerly with Mike Crapo · FORBES-TATE · Apr 17, 2026
  • Robin L. Kelly
    Earl Flood House New Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen. Claire McCaskill) Formerly with Robin L. Kelly · MEHLMAN CONSULTING, INC. · Jan 16, 2026
  • Shelley Moore Capito
    Joseph Brown Senate New Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci) Formerly with Shelley Moore Capito · MEHLMAN CONSULTING, INC. · Oct 17, 2025
See all 46 on the Revolving Door dashboard

RARE Estimated quarterly lobbying spending

RARE Revenue by Segment or Geography

By Segment
By Geography
RARE Income Statement
RARE Balance Sheet
RARE Cash Flow
U.S. Patents

New RARE patent grants

  • Patent Title: Therapeutics for glycogen storage disease type iii Aug. 11, 2026
  • Patent Title: Methods and compositions for treating glycogen storage diseases Jul. 28, 2026
  • Patent Title: Gene therapy for treating propionic acidemia Jul. 21, 2026
  • Patent Title: Gene therapy for treating cdkl5 deficiency disorder Jun. 09, 2026
  • Patent Title: Compositions of triglycerides and uses thereof Feb. 17, 2026
  • Patent Title: Methods for improved therapeutic use of recombinant aav Feb. 10, 2026
  • Patent Title: Scalable method for producing transfection reagents Dec. 02, 2025
  • Patent Title: Gene therapy for treating propionic acidemia Nov. 18, 2025
  • Patent Title: Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d Jul. 15, 2025
  • Patent Title: Gene therapy constructs for treating wilson disease Jun. 24, 2025
  • Patent Title: Engineered producer cell lines and methods of making and using the same Jun. 25, 2024
  • Patent Title: Methods of heat inactivation of adenovirus Apr. 02, 2024
  • Patent Title: Cell culture methods involving hdac inhibitors or rep proteins Feb. 13, 2024
  • Patent Title: Use of tonicifying agents to enhance recombinant adeno-associated virus yield Oct. 24, 2023
  • Patent Title: Methods for treating tumor-induced osteomalacia Oct. 03, 2023
  • Patent Title: Creatine prodrugs, compositions and methods of use thereof Sep. 12, 2023
  • Patent Title: Therapeutics for glycogen storage disease type iii Jul. 05, 2022
  • Patent Title: Creatine prodrugs, compositions and methods of use thereof May. 17, 2022
  • Patent Title: Methods for treating hypophosphatemic disorders Dec. 21, 2021
  • Patent Title: Methods of heat inactivation of adenovirus May. 25, 2021
  • Patent Title: Sialic acid analogs Jan. 12, 2021
  • Patent Title: Methods for treating hypophosphatemic disorders May. 05, 2020
  • Patent Title: Sialic acid analogs Oct. 29, 2019
  • Patent Title: Crystal forms of sialic acid or salt or solvate thereof Aug. 20, 2019
  • Patent Title: Sialic acid analogs Sep. 04, 2018
  • Patent Title: Sialylated glycoprotein compositons and uses thereof Jun. 27, 2017
  • Patent Title: Methods and formulations for treating sialic acid deficiencies Jan. 31, 2017
  • Patent Title: Methods and formulations for treating sialic acid deficiencies Dec. 06, 2016
  • Patent Title: Sialylated glycoprotein compositions and uses thereof Oct. 04, 2016
  • Patent Title: Sialylated glycoprotein compositions and uses thereof Oct. 04, 2016
  • Patent Title: Methods and formulations for treating sialic acid deficiencies Jan. 26, 2016
  • Patent Title: Sialic acid analogs Dec. 29, 2015
  • Patent Title: Sialic acid analogs Sep. 23, 2014
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to RARE from public contracts

RARE News

Recent insights relating to RARE

CNBC Recommendations

Recent picks made for RARE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RARE

RARE Analyst Ratings

RARE Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RARE Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RARE stock a Buy, Sell, or Hold?

  • What is the price target for $RARE stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RARE Top Shareholders
Shareholder
Shares Held
RARE Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RARE stock?

  • Who owns the most shares of $RARE stock?

  • What funds own $RARE stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RARE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RARE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About RARE

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

  • Address Novato, CA
  • Market Cap 1.5 billion
  • Employees 1,371
  • Industrial Classification Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc. (RARE) Historical Stock Prices

Ultragenyx Pharmaceutical Inc. (RARE) closed at $15.62 on September 22, 2026. Over the past year its adjusted close ranged from $12.88 to $36.54. Daily prices go back to January 31, 2014, 3,179 trading days in all.

  • 1 month-39.55%
  • 3 months-45.71%
  • Year to date-32.11%
  • 1 year-47.01%
  • 3 years-57.14%
  • 5 years-83.98%
  • Max-63.04%
See every congressional and insider trade on the RARE price chart

Quiver Premium charts RARE's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 14.78 16.12 14.47 15.62 15.62 8,134,199
Sep 21, 2026 14.58 15.01 14.28 14.65 14.65 5,270,376
Sep 18, 2026 14.79 15.07 14.07 14.51 14.51 13,335,258
Sep 17, 2026 13.22 14.57 13.20 14.50 14.50 12,427,775
Sep 16, 2026 13.07 13.22 12.73 12.88 12.88 5,031,174
Sep 15, 2026 13.56 13.59 12.88 13.07 13.07 5,655,014
Sep 14, 2026 14.44 14.44 13.60 13.61 13.61 5,929,198
Sep 11, 2026 14.43 14.70 14.13 14.30 14.30 3,253,692
Sep 10, 2026 14.25 14.44 13.95 14.40 14.40 3,665,282
Sep 9, 2026 14.77 15.19 14.27 14.31 14.31 4,576,648
Sep 8, 2026 15.10 15.25 14.63 14.88 14.88 5,926,471
Sep 4, 2026 15.47 16.08 15.23 15.30 15.30 11,494,472
Sep 3, 2026 14.00 15.00 13.81 14.85 14.85 27,159,724
Sep 2, 2026 25.96 26.80 25.57 26.53 26.53 7,170,810
Sep 1, 2026 25.21 25.85 25.11 25.81 25.81 1,872,066
Aug 31, 2026 25.45 25.90 24.73 25.21 25.21 1,934,100
Aug 28, 2026 26.54 26.73 25.37 25.61 25.61 1,612,887
Aug 27, 2026 26.38 26.56 25.83 26.26 26.26 1,142,858
Aug 26, 2026 26.55 26.66 25.61 26.44 26.44 1,667,810
Aug 25, 2026 26.25 26.91 26.00 26.46 26.46 3,807,810
Aug 24, 2026 25.75 26.09 25.30 25.72 25.72 1,536,973
Aug 21, 2026 25.76 26.75 25.69 25.83 25.83 2,396,765
Aug 20, 2026 28.39 28.50 25.04 25.32 25.32 3,841,137
Aug 19, 2026 26.28 26.68 26.00 26.24 26.24 2,846,576
Aug 18, 2026 25.68 26.11 24.97 25.49 25.49 1,793,436
Aug 17, 2026 26.26 26.51 25.81 26.13 26.13 1,316,013
Aug 14, 2026 26.30 26.58 25.75 26.49 26.49 1,222,222
Aug 13, 2026 27.07 27.17 26.33 26.38 26.38 946,127
Aug 12, 2026 26.79 27.16 26.11 26.86 26.86 1,545,158
Aug 11, 2026 27.16 27.59 26.42 26.96 26.96 2,138,831
Aug 10, 2026 25.91 27.11 25.51 26.80 26.80 2,364,777
Aug 7, 2026 26.34 26.71 25.30 25.91 25.91 3,829,202
Aug 6, 2026 24.99 26.10 24.80 25.82 25.82 1,960,488
Aug 5, 2026 28.48 28.48 24.61 24.93 24.93 2,642,397
Aug 4, 2026 25.19 26.13 25.00 25.81 25.81 2,103,772
Aug 3, 2026 24.92 25.40 24.01 25.02 25.02 2,085,743
Jul 31, 2026 25.95 26.07 24.59 24.91 24.91 1,537,765
Jul 30, 2026 25.04 26.10 24.55 26.04 26.04 2,675,794
Jul 29, 2026 25.77 26.15 24.87 25.00 25.00 2,330,792
Jul 28, 2026 26.57 27.29 25.22 25.98 25.98 1,844,368
Jul 27, 2026 27.37 28.00 26.69 26.89 26.89 1,766,760
Jul 24, 2026 27.32 27.48 26.50 26.90 26.90 1,495,624
Jul 23, 2026 27.28 28.05 27.00 27.02 27.02 1,888,467
Jul 22, 2026 28.62 28.86 27.50 27.64 27.64 1,546,510
Jul 21, 2026 29.00 29.10 28.23 28.62 28.62 2,275,867
Jul 20, 2026 29.33 30.03 28.50 28.53 28.53 1,255,077
Jul 17, 2026 29.16 30.07 28.90 29.28 29.28 1,500,530
Jul 16, 2026 31.86 31.90 29.83 30.22 30.22 1,829,572
Jul 15, 2026 31.61 31.80 30.64 31.71 31.71 1,012,610
Jul 14, 2026 33.36 33.58 31.91 32.03 32.03 1,078,132
Jul 13, 2026 33.06 33.30 31.81 33.22 33.22 1,394,276
Jul 10, 2026 34.61 34.81 32.72 33.82 33.82 1,578,134
Jul 9, 2026 34.71 34.80 33.34 34.61 34.61 1,942,584
Jul 8, 2026 35.24 35.79 34.20 34.67 34.67 2,775,854
Jul 7, 2026 34.19 36.57 33.57 35.87 35.87 4,421,797
Jul 6, 2026 33.28 34.19 32.89 33.70 33.70 1,553,103
Jul 2, 2026 32.80 33.50 32.48 33.47 33.47 1,239,269
Jul 1, 2026 33.13 33.49 32.34 32.38 32.38 2,635,814
Jun 30, 2026 31.01 35.00 30.48 33.39 33.39 6,939,359
Jun 29, 2026 30.77 31.16 30.19 30.68 30.68 3,995,159
Jun 26, 2026 29.39 30.99 29.36 30.77 30.77 17,178,496
Jun 25, 2026 29.51 30.57 29.07 29.25 29.25 1,926,020
Jun 24, 2026 29.02 30.14 29.01 29.11 29.11 1,727,750
Jun 23, 2026 28.58 29.39 28.50 28.76 28.76 2,043,024
Jun 22, 2026 27.56 29.35 27.49 29.03 29.03 2,067,508
Jun 18, 2026 27.54 28.18 27.31 27.44 27.44 3,562,450
Jun 17, 2026 25.09 27.90 25.09 26.91 26.91 3,242,963
Jun 16, 2026 25.54 25.66 24.51 24.85 24.85 2,747,383
Jun 15, 2026 24.62 25.38 24.50 25.38 25.38 1,479,242
Jun 12, 2026 24.08 24.81 24.00 24.35 24.35 1,846,693
Jun 11, 2026 22.93 24.08 22.48 23.98 23.98 1,527,247
Jun 10, 2026 22.56 23.23 22.43 22.97 22.97 1,200,756
Jun 9, 2026 22.14 23.05 22.03 22.79 22.79 1,622,579
Jun 8, 2026 22.15 22.29 21.39 21.59 21.59 1,689,366
Jun 5, 2026 23.31 23.41 21.74 21.91 21.91 1,117,024
Jun 4, 2026 22.51 23.47 22.18 23.31 23.31 1,412,117
Jun 3, 2026 21.85 22.61 21.80 22.41 22.41 1,799,442
Jun 2, 2026 22.49 22.64 21.33 21.78 21.78 2,029,040
Jun 1, 2026 23.77 24.05 22.62 22.85 22.85 2,327,957
May 29, 2026 23.56 24.07 23.30 23.94 23.94 1,844,053
May 28, 2026 23.41 23.90 22.74 23.26 23.26 1,257,970
May 27, 2026 23.13 23.55 23.00 23.39 23.39 1,685,021
May 26, 2026 23.62 23.75 23.01 23.14 23.14 1,219,447
May 22, 2026 23.68 24.12 23.25 23.39 23.39 1,130,550
May 21, 2026 23.42 24.12 23.11 23.71 23.71 1,272,125
May 20, 2026 22.55 23.72 22.55 23.37 23.37 1,547,854
May 19, 2026 24.20 24.41 22.23 22.45 22.45 2,121,475
May 18, 2026 25.12 25.17 23.98 24.19 24.19 1,548,682
May 15, 2026 25.71 25.95 24.84 25.00 25.00 1,519,285
May 14, 2026 26.53 26.67 25.77 25.80 25.80 1,161,379
May 13, 2026 26.61 26.94 26.21 26.46 26.46 1,363,335
May 12, 2026 26.38 26.89 26.01 26.84 26.84 1,265,789
May 11, 2026 26.45 27.42 26.21 26.30 26.30 1,861,673
May 8, 2026 26.05 26.67 25.93 26.12 26.12 1,557,063
May 7, 2026 26.16 26.50 25.53 26.13 26.13 1,978,688
May 6, 2026 25.91 27.27 24.23 25.93 25.93 3,454,791
May 5, 2026 24.96 25.32 24.45 25.01 25.01 1,481,952
May 4, 2026 24.69 25.32 24.49 24.81 24.81 1,849,256
May 1, 2026 24.90 25.11 24.36 24.77 24.77 1,407,228
Apr 30, 2026 24.52 25.07 24.17 24.69 24.69 1,790,724
Apr 29, 2026 24.13 24.76 23.71 24.18 24.18 2,058,771
Apr 28, 2026 24.32 25.14 24.25 24.53 24.53 1,725,260
Apr 27, 2026 24.15 25.05 23.78 23.99 23.99 1,810,348
Apr 24, 2026 24.37 24.44 23.68 24.10 24.10 1,538,236
Apr 23, 2026 24.60 25.11 23.95 24.28 24.28 1,464,509
Apr 22, 2026 24.31 24.72 24.05 24.61 24.61 1,349,181
Apr 21, 2026 25.17 25.21 23.95 24.10 24.10 1,387,164
Apr 20, 2026 24.62 25.28 24.25 25.06 25.06 1,447,708
Apr 17, 2026 24.94 25.24 24.54 24.81 24.81 1,725,538
Apr 16, 2026 25.64 26.19 24.33 24.52 24.52 1,812,338
Apr 15, 2026 24.75 25.45 24.71 25.18 25.18 1,943,960
Apr 14, 2026 23.35 24.74 23.35 24.57 24.57 1,820,008
Apr 13, 2026 23.11 24.12 23.01 23.63 23.63 1,472,457
Apr 10, 2026 24.02 24.13 23.06 23.30 23.30 1,551,328
Apr 9, 2026 22.92 24.12 22.92 23.91 23.91 1,965,749
Apr 8, 2026 23.64 23.99 22.88 23.15 23.15 1,615,498
Apr 7, 2026 22.91 23.18 22.34 23.15 23.15 1,478,494
Apr 6, 2026 22.45 22.97 22.28 22.87 22.87 1,352,287
Apr 2, 2026 21.05 22.45 20.79 22.45 22.45 1,772,484
Apr 1, 2026 20.97 21.56 20.92 21.42 21.42 2,310,481
Mar 31, 2026 19.98 21.07 19.54 20.95 20.95 2,964,147
Mar 30, 2026 19.48 19.77 19.13 19.30 19.30 3,655,448
Mar 27, 2026 20.00 20.09 19.10 19.38 19.38 1,530,550
Mar 26, 2026 19.69 20.45 19.61 20.00 20.00 2,293,889
Mar 25, 2026 18.75 19.94 18.70 19.85 19.85 1,892,301
Mar 24, 2026 19.36 19.40 18.29 18.50 18.50 3,782,751
Mar 23, 2026 20.18 20.32 19.53 20.27 20.27 2,065,809
Mar 20, 2026 20.52 20.68 19.86 19.87 19.87 3,797,567
Mar 19, 2026 20.16 20.57 19.90 20.42 20.42 1,654,061
Mar 18, 2026 21.37 21.50 20.39 20.46 20.46 2,879,916
Mar 17, 2026 21.80 22.20 21.55 21.60 21.60 1,401,070
Mar 16, 2026 21.57 22.00 21.39 21.82 21.82 980,824
Mar 13, 2026 21.94 22.27 21.29 21.34 21.34 2,543,334
Mar 12, 2026 21.93 22.29 21.12 21.71 21.71 1,463,050
Mar 11, 2026 22.78 22.84 21.74 22.21 22.21 3,501,399
Mar 10, 2026 22.74 23.19 22.38 22.84 22.84 1,138,357
Mar 9, 2026 21.40 22.81 21.37 22.61 22.61 2,257,195
Mar 6, 2026 21.26 21.41 20.61 21.25 21.25 2,148,915
Mar 5, 2026 21.58 21.98 21.39 21.46 21.46 2,426,613
Mar 4, 2026 22.07 22.19 21.47 21.80 21.80 2,277,062
Mar 3, 2026 22.40 22.88 21.88 22.07 22.07 1,722,117
Mar 2, 2026 22.54 23.19 22.51 23.02 23.02 1,668,388
Feb 27, 2026 22.95 23.45 22.54 23.39 23.39 1,405,262
Feb 26, 2026 22.83 23.17 22.48 23.04 23.04 1,341,530
Feb 25, 2026 22.72 23.08 22.46 22.91 22.91 1,095,094
Feb 24, 2026 22.65 23.00 22.41 22.75 22.75 1,429,749
Feb 23, 2026 22.89 23.79 22.39 22.51 22.51 2,234,313
Feb 20, 2026 21.56 22.87 21.31 22.72 22.72 2,130,122
Feb 19, 2026 20.41 22.16 20.08 21.83 21.83 2,351,800
Feb 18, 2026 20.00 20.61 19.63 20.45 20.45 2,113,176
Feb 17, 2026 20.65 20.89 19.78 20.18 20.18 3,155,585
Feb 13, 2026 21.54 23.17 19.61 20.52 20.52 7,200,566
Feb 12, 2026 23.96 24.35 22.93 23.50 23.50 1,893,915
Feb 11, 2026 24.23 24.35 23.27 23.88 23.88 1,402,702
Feb 10, 2026 23.49 24.68 23.49 24.20 24.20 1,216,269
Feb 9, 2026 24.66 24.67 23.78 23.88 23.88 1,707,205
Feb 6, 2026 24.25 24.87 23.89 24.70 24.70 2,679,737
Feb 5, 2026 24.59 24.93 23.76 23.79 23.79 1,720,623
Feb 4, 2026 25.07 25.07 24.08 24.69 24.69 1,859,848
Feb 3, 2026 24.92 25.82 24.36 24.80 24.80 2,604,807
Feb 2, 2026 23.56 24.91 23.56 24.76 24.76 3,438,065
Jan 30, 2026 24.13 24.59 23.26 24.07 24.07 3,775,613
Jan 29, 2026 24.40 24.70 23.98 24.27 24.27 1,688,983
Jan 28, 2026 24.96 24.96 24.33 24.44 24.44 1,810,308
Jan 27, 2026 24.23 25.00 24.23 24.62 24.62 1,629,423
Jan 26, 2026 24.10 24.90 24.09 24.31 24.31 1,859,454
Jan 23, 2026 23.37 24.53 23.16 24.21 24.21 3,695,693
Jan 22, 2026 22.78 23.87 22.71 23.40 23.40 2,323,985
Jan 21, 2026 22.72 22.98 22.49 22.75 22.75 3,048,947
Jan 20, 2026 22.12 22.96 22.00 22.63 22.63 2,275,887
Jan 16, 2026 23.36 23.77 22.43 22.49 22.49 1,900,763
Jan 15, 2026 23.87 24.12 23.09 23.50 23.50 1,760,826
Jan 14, 2026 24.12 24.32 23.71 24.07 24.07 2,264,970
Jan 13, 2026 24.48 24.52 23.47 24.11 24.11 3,545,118
Jan 12, 2026 22.95 24.65 22.40 24.37 24.37 4,596,712
Jan 9, 2026 23.46 23.90 22.50 22.51 22.51 2,764,723
Jan 8, 2026 24.30 25.09 22.92 23.21 23.21 2,681,888
Jan 7, 2026 22.86 24.62 22.73 24.20 24.20 4,460,466
Jan 6, 2026 22.94 23.16 22.07 22.54 22.54 3,744,674
Jan 5, 2026 23.42 23.75 22.64 23.11 23.11 3,956,405
Jan 2, 2026 22.84 24.00 22.50 23.60 23.60 3,639,964
Dec 31, 2025 22.50 23.06 21.90 23.00 23.00 3,677,438
Dec 30, 2025 19.85 22.87 19.80 22.78 22.78 11,045,719
Dec 29, 2025 19.32 20.49 18.41 19.72 19.72 21,699,768
Dec 26, 2025 34.38 34.47 33.90 34.19 34.19 629,207
Dec 24, 2025 34.49 34.76 34.13 34.58 34.58 721,613
Dec 23, 2025 34.73 34.89 34.07 34.13 34.13 841,289
Dec 22, 2025 33.57 35.12 33.21 34.75 34.75 2,342,867
Dec 19, 2025 32.84 34.03 32.65 33.50 33.50 2,497,189
Dec 18, 2025 33.31 34.17 32.64 32.84 32.84 1,475,291
Dec 17, 2025 34.43 34.64 32.84 33.21 33.21 1,791,563
Dec 16, 2025 36.05 36.54 34.19 34.34 34.34 1,487,907
Dec 15, 2025 36.68 36.81 35.82 36.23 36.23 1,715,239
Dec 12, 2025 36.39 36.54 35.93 36.23 36.23 1,589,483
Dec 11, 2025 36.42 36.74 35.91 36.20 36.20 1,321,276
Dec 10, 2025 36.38 36.48 35.65 36.00 36.00 1,684,749
Dec 9, 2025 36.39 36.71 35.68 36.30 36.30 2,409,203
Dec 8, 2025 39.00 39.89 36.22 36.45 36.45 1,659,326
Dec 5, 2025 36.62 37.25 35.94 36.38 36.38 1,281,816
Dec 4, 2025 36.46 37.25 36.08 36.54 36.54 1,242,944
Dec 3, 2025 33.53 36.54 33.48 36.45 36.45 2,023,170
Dec 2, 2025 33.37 34.09 33.16 33.47 33.47 949,792
Dec 1, 2025 34.31 34.37 33.19 33.37 33.37 1,042,679
Nov 28, 2025 33.82 34.84 33.60 34.75 34.75 785,180
Nov 26, 2025 33.22 34.00 32.98 33.76 33.76 1,304,200
Nov 25, 2025 33.09 33.59 32.06 33.52 33.52 1,514,105
Nov 24, 2025 33.33 34.21 32.58 32.78 32.78 1,878,437
Nov 21, 2025 31.52 33.79 31.25 33.59 33.59 1,682,978
Nov 20, 2025 32.25 32.91 31.00 31.18 31.18 1,028,333
Nov 19, 2025 32.66 32.89 31.48 31.86 31.86 1,068,056
Nov 18, 2025 32.38 33.21 31.85 32.83 32.83 930,017
Nov 17, 2025 32.80 33.41 32.31 32.54 32.54 1,117,271
Nov 14, 2025 32.42 34.01 32.38 33.08 33.08 1,265,295
Nov 13, 2025 32.93 33.82 32.41 32.90 32.90 1,257,232
Nov 12, 2025 33.25 33.74 32.95 33.53 33.53 1,078,903
Nov 11, 2025 31.95 33.28 31.50 33.25 33.25 1,172,368
Nov 10, 2025 31.11 32.08 30.38 31.94 31.94 1,157,164
Nov 7, 2025 30.42 30.75 29.36 30.63 30.63 1,355,360
Nov 6, 2025 31.85 31.88 30.05 30.95 30.95 1,872,496
Nov 5, 2025 28.90 32.25 28.56 31.87 31.87 2,780,698
Nov 4, 2025 32.97 33.50 32.41 32.46 32.46 1,524,778
Nov 3, 2025 34.00 34.96 32.94 33.47 33.47 1,407,583
Oct 31, 2025 34.99 35.38 34.35 34.60 34.60 1,267,731
Oct 30, 2025 34.37 35.57 34.26 35.17 35.17 1,107,873
Oct 29, 2025 34.53 35.77 33.94 34.59 34.59 1,264,900
Oct 28, 2025 34.91 35.95 34.47 34.77 34.77 1,188,028
Oct 27, 2025 34.41 35.48 34.00 35.31 35.31 1,745,976
Oct 24, 2025 33.69 34.21 33.25 33.53 33.53 1,083,559
Oct 23, 2025 33.21 34.11 33.02 33.63 33.63 1,002,485
Oct 22, 2025 34.05 34.33 33.10 33.14 33.14 934,492
Oct 21, 2025 34.16 34.78 33.89 34.19 34.19 1,179,186
Oct 20, 2025 33.29 34.75 33.05 34.40 34.40 1,306,720
Oct 17, 2025 33.84 34.22 32.39 32.63 32.63 1,238,730
Oct 16, 2025 33.74 34.50 33.30 33.97 33.97 2,046,186
Oct 15, 2025 31.77 33.57 31.60 33.43 33.43 1,570,378
Oct 14, 2025 31.95 32.14 31.44 31.69 31.69 1,229,112
Oct 13, 2025 31.51 32.30 31.37 32.02 32.02 1,003,315
Oct 10, 2025 31.81 31.84 30.93 31.45 31.45 1,574,174
Oct 9, 2025 31.01 32.10 30.93 31.66 31.66 1,642,776
Oct 8, 2025 29.74 31.51 29.60 30.86 30.86 1,276,444
Oct 7, 2025 30.49 30.52 29.57 29.74 29.74 1,452,254
Oct 6, 2025 31.42 31.70 30.15 30.19 30.19 1,320,520
Oct 3, 2025 31.04 31.62 30.82 31.21 31.21 1,364,503
Oct 2, 2025 30.21 30.93 29.81 30.90 30.90 1,224,156
Oct 1, 2025 30.22 30.86 29.59 29.99 29.99 1,961,783
Sep 30, 2025 30.44 30.60 29.63 30.08 30.08 1,623,559
Sep 29, 2025 29.26 31.15 29.02 30.36 30.36 2,408,438
Sep 26, 2025 28.00 29.34 27.99 29.08 29.08 2,659,258
Sep 25, 2025 28.70 28.70 27.75 27.82 27.82 1,611,600
Sep 24, 2025 28.38 29.05 28.05 28.76 28.76 1,753,466
Sep 23, 2025 29.39 29.64 28.28 28.40 28.40 1,389,135
Sep 22, 2025 28.22 29.70 27.88 29.47 29.47 1,600,355

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Ultragenyx Pharmaceutical Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at RARE, per a recent SEC DEF 14A filing. We estimate that the median employee at Ultragenyx Pharmaceutical Inc. is paid $325,295.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation